Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8SB1 | 8SB1 | CryoEM structure of DH270.I3-CH848.10.17 | |
| 8SB2 | A0A1W6IPB2 | CryoEM structure of DH270.I2-CH848.10.17 | |
| 8SB2 | 8SB2 | CryoEM structure of DH270.I2-CH848.10.17 | |
| 8SB3 | A0A1W6IPB2 | CryoEM structure of DH270.2-CH848.10.17 | |
| 8SB3 | 8SB3 | CryoEM structure of DH270.2-CH848.10.17 | |
| 8SB4 | A0A1W6IPB2 | CryoEM structure of DH270.1-CH848.10.17 | |
| 8SB4 | 8SB4 | CryoEM structure of DH270.1-CH848.10.17 | |
| 8SB5 | A0A1W6IPB2 | CryoEM structure of DH270.I1.6-CH848.10.17 | |
| 8SB5 | 8SB5 | CryoEM structure of DH270.I1.6-CH848.10.17 | |
| 8SBU | P0AEX9 | Crystal structure of MBP fusion with HPPK from Methanocaldococcus jannaschii | |
| 8SBU | Q59028 | Crystal structure of MBP fusion with HPPK from Methanocaldococcus jannaschii | |
| 8SD2 | P03452 | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with small molecule fusion inhibitor compound 4 | |
| 8SD4 | P03452 | Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with small molecule fusion inhibitor compound 7 | |
| 8SDB | P07762 | Crystal Structure of E.Coli Branching Enzyme in complex with malto-octose | |
| 8SDF | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 | |
| 8SDF | 8SDF | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 | |
| 8SDG | 8SDG | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43 | |
| 8SDG | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43 | |
| 8SDH | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 | |
| 8SDH | 8SDH | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 | |
| 8SGA | 8SGA | Crystal structure of 770E11, a monoclonal antibody isolated from a human Epstein-Barr virus seropositive donor | |
| 8SGB | P15813 | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
| 8SGB | P61769 | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
| 8SGB | 8SGB | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
| 8SGM | P15813 | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
| 8SGM | P61769 | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
| 8SGM | 8SGM | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
| 8SGN | P03200 | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy651H02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SGN | 8SGN | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy651H02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SGO | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate | |
| 8SGO | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate | |
| 8SGO | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate | |
| 8SGO | 8SGO | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate | |
| 8SGU | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain | |
| 8SGW | A0A8D0Z6H8 | Pendrin in complex with chloride | |
| 8SI9 | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
| 8SI9 | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
| 8SI9 | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
| 8SI9 | 8SI9 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
| 8SIC | 8SIC | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SIC | P03200 | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SID | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
| 8SID | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
| 8SID | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
| 8SID | 8SID | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
| 8SIE | A0A8D0Z6H8 | Pendrin in complex with bicarbonate | |
| 8SIQ | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 8SIQ | 8SIQ | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 8SIR | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
| 8SIR | 8SIR | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab |
